Daily Wellness Notes

MedCity News Healthcare technology news, life science current events

  • Digital Platforms Give Consumers a Map to Navigate New Ways to Access Medicines
    by Frank Vinluan on November 20, 2026 at 10:35 pm

    Direct-to-consumer platforms for prescription medicines are growing, but patients need support to use them as part of a broader journey through the healthcare system. Such platforms were the topic of a recent panel discussion at MedCity News’ recent INVEST Digital Health Conference. The post Digital Platforms Give Consumers a Map to Navigate New Ways to Access Medicines appeared first on MedCity News.

  • 15 Organizations Call on Congress to Address Abuse of Drug Patent System
    by Marissa Plescia on November 20, 2026 at 9:07 pm

    Fifteen consumer advocacy groups urged Congress to reform drug patent laws, arguing pharmaceutical companies exploit them to delay competition and raise prices. The post 15 Organizations Call on Congress to Address Abuse of Drug Patent System appeared first on MedCity News.

  • What HEDIS Can’t See in an Asthma Follow-Up Visit
    by Gary Falcetano on November 20, 2026 at 2:44 pm

    This opportunity that HEDIS has created for patients who were too often discharged and forgotten is well past due — but it’s up to clinicians to take it a step further to figure out why each patient lost control. The post What HEDIS Can’t See in an Asthma Follow-Up Visit appeared first on MedCity News.

  • Who Should Make Medical-Necessity Decisions: AI, Insurers or Treating Physicians?
    by Marissa Plescia on November 19, 2026 at 11:44 pm

    On a panel at HLTH, experts discussed prior authorization denials and who should make the final call. The post Who Should Make Medical-Necessity Decisions: AI, Insurers or Treating Physicians? appeared first on MedCity News.

  • Independent Benefits Platform Leader: Market Forces Prevent Employers From Getting Best Solution
    by Arundhati Parmar on November 19, 2026 at 10:44 pm

    On a panel on employee benefits Ali Diab, CEO of Collective Health, spoke plainly about the market forces that hamper self-insured employers from designing the best employee benefits. The post Independent Benefits Platform Leader: Market Forces Prevent Employers From Getting Best Solution appeared first on MedCity News.

  • FDA Approval for Sanofi Drug Marks an Important First in Rare Disease
    by Frank Vinluan on November 19, 2026 at 9:41 pm

    Sanofi’s Infilbray is now approved for treating Gaucher disease type 3. The brain-penetrating small molecule is the first FDA-approved therapy for the neurological symptoms of this rare enzyme deficiency. The post FDA Approval for Sanofi Drug Marks an Important First in Rare Disease appeared first on MedCity News.

  • When GLP-1 Costs Mask the Value of Care Management
    by Mary Bacaj on November 19, 2026 at 2:32 pm

    What would your fund’s claims report look like this year without GLP-1s? It’s worth asking before deciding whether your care management program is working. The post When GLP-1 Costs Mask the Value of Care Management appeared first on MedCity News.

  • Hone Health Secures $228M for Longevity Platform
    by Marissa Plescia on November 18, 2026 at 11:19 pm

    Hone Health’s funding includes $28 million in equity as Series A financing, as well as $200 million in growth financing from General Catalyst’s Customer Value Fund.  The post Hone Health Secures $228M for Longevity Platform appeared first on MedCity News.

  • Pfizer’s Immunology Strategy Expands to In Vivo Cell Therapy With Starna Deal
    by Frank Vinluan on November 18, 2026 at 7:25 pm

    Pfizer gains global rights, excluding Greater China, to three in vivo CAR-T cell therapies from Starna Therapeutics in preclinical development for undisclosed autoimmune diseases. It’s the latest in a series of big pharma business deals involving in vivo cell therapy assets and platform technologies. The post Pfizer’s Immunology Strategy Expands to In Vivo Cell Therapy With Starna Deal appeared first on MedCity News.

  • Abridge Announcements during HLTH Emphasize Growing Healthcare Trend
    by Jenna Congdon on November 18, 2026 at 6:12 pm

    News emerging during the annual HLTH conference, including ones from Abridge, reflects the growing use of AI in clinical practice, emphasizing the need to bring clinical information into the workflows providers already use. The post Abridge Announcements during HLTH Emphasize Growing Healthcare Trend appeared first on MedCity News.

  • I’ve Practiced Medicine for 40 Years — AI Gave Me Back My Evenings
    by Dr. Michael Miller on November 18, 2026 at 2:20 pm

    If you’re a physician earlier in your career, the message is simple: whatever tools exist to get your evenings back, use them now, while you still have the evenings to spend them on. The post I’ve Practiced Medicine for 40 Years — AI Gave Me Back My Evenings appeared first on MedCity News.

  • Teladoc Launches Employer Contribution Option for GLP-1s
    by Marissa Plescia on November 18, 2026 at 3:04 am

    Teladoc launched a new offering that allows employers to contribute toward the cost of GLP-1 medications. The post Teladoc Launches Employer Contribution Option for GLP-1s appeared first on MedCity News.

  • Viz.ai Partners with Wolters Kluwer Health to Add UpToDate Resource to its Platform
    by Jenna Congdon on November 17, 2026 at 11:50 pm

    Health systems are jumping to integrate AI into clinicians’ everyday tools. When those platforms also offer the medical evidence that healthcare providers need to make on-the-fly clinical decisions, patient care can improve. Viz.ai and Wolters Kluwer Health are partnering to do just that. The post Viz.ai Partners with Wolters Kluwer Health to Add UpToDate Resource to its Platform appeared first on MedCity News.

  • Marrow Therapeutics Unveils $173M for ‘Trojan Horse’ Delivery of Blood Disorder Drugs
    by Frank Vinluan on November 17, 2026 at 10:41 pm

    Sickle cell disease and beta thalassemia are the startup’s lead indications. While gene therapies are available for both blood disorders, Marrow executives say manufacturing and dosing advantages could make their medicine more broadly accessible across the world. The post Marrow Therapeutics Unveils $173M for ‘Trojan Horse’ Delivery of Blood Disorder Drugs appeared first on MedCity News.

  • Your AI Vendor’s Medical Exam Score Doesn’t Mean What You Think It Does
    by David Talby on November 17, 2026 at 2:48 pm

    If health systems want to adopt AI at scale, they need evaluation that is open, reproducible, and continuously updated. That’s also much harder to build in healthcare than in general-purpose AI, for these 3 reasons. The post Your AI Vendor’s Medical Exam Score Doesn’t Mean What You Think It Does appeared first on MedCity News.